Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1982 2
1983 1
1984 1
1985 2
1988 4
1990 2
1991 2
1992 1
1993 2
1994 1
1995 4
1996 3
1997 6
1998 5
1999 7
2000 4
2001 5
2002 5
2003 3
2004 8
2005 2
2006 9
2007 9
2008 4
2009 9
2010 3
2011 7
2012 5
2013 12
2014 12
2015 5
2016 9
2017 11
2018 9
2019 17
2020 16
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 9310521

190 results
Results by year
Filters applied: . Clear all
Page 1
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
Soutullo C, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Bloomfield R, Squires LA, Coghill DR. Soutullo C, et al. CNS Drugs. 2013 Sep;27(9):743-51. doi: 10.1007/s40263-013-0086-6. CNS Drugs. 2013. PMID: 23801529 Free PMC article. Clinical Trial.
A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH. Stein MA, et al. Pediatrics. 2003 Nov;112(5):e404. doi: 10.1542/peds.112.5.e404. Pediatrics. 2003. PMID: 14595084 Clinical Trial.
Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
Pliszka SR, Wilens TE, Bostrom S, Arnold VK, Marraffino A, Cutler AJ, López FA, DeSousa NJ, Sallee FR, Incledon B, Newcorn JH. Pliszka SR, et al. J Child Adolesc Psychopharmacol. 2017 Aug;27(6):474-482. doi: 10.1089/cap.2017.0084. Epub 2017 Jul 21. J Child Adolesc Psychopharmacol. 2017. PMID: 29172680 Free PMC article. Clinical Trial.
Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.
Stein MA, Waldman ID, Charney E, Aryal S, Sable C, Gruber R, Newcorn JH. Stein MA, et al. J Child Adolesc Psychopharmacol. 2011 Dec;21(6):581-8. doi: 10.1089/cap.2011.0018. Epub 2011 Dec 2. J Child Adolesc Psychopharmacol. 2011. PMID: 22136094 Free PMC article. Clinical Trial.
Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
Ramtvedt BE, Aabech HS, Sundet K. Ramtvedt BE, et al. J Child Adolesc Psychopharmacol. 2014 Apr;24(3):130-9. doi: 10.1089/cap.2013.0114. Epub 2014 Mar 25. J Child Adolesc Psychopharmacol. 2014. PMID: 24666268 Free PMC article. Clinical Trial.
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Lyne A, Squires L. Coghill D, et al. Eur Neuropsychopharmacol. 2013 Oct;23(10):1208-18. doi: 10.1016/j.euroneuro.2012.11.012. Epub 2013 Jan 15. Eur Neuropsychopharmacol. 2013. PMID: 23332456 Free article. Clinical Trial.
190 results
Jump to page
Feedback